These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 31434666

  • 1. Utility of autonomic testing for the efficient diagnosis and effective pharmacological management of neurogenic orthostatic hypotension.
    Alam SB, Almardini W, Suleman A.
    BMJ Case Rep; 2019 Aug 20; 12(8):. PubMed ID: 31434666
    [Abstract] [Full Text] [Related]

  • 2. Persistent unexplained chest pain and dyspnea in a patient with coronary artery disease: a case report.
    Mobarek SK.
    BMC Cardiovasc Disord; 2020 Feb 04; 20(1):54. PubMed ID: 32019498
    [Abstract] [Full Text] [Related]

  • 3. Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa.
    Isaacson SH, Skettini J.
    Vasc Health Risk Manag; 2014 Feb 04; 10():169-76. PubMed ID: 24729712
    [Abstract] [Full Text] [Related]

  • 4. New developments in the management of neurogenic orthostatic hypotension.
    Biaggioni I.
    Curr Cardiol Rep; 2014 Nov 04; 16(11):542. PubMed ID: 25303896
    [Abstract] [Full Text] [Related]

  • 5. Defining successful treatment of neurogenic orthostatic hypotension with droxidopa in a patient with multiple system atrophy.
    Goodman BP, Gupta F.
    Clin Auton Res; 2017 Jul 04; 27(Suppl 1):21-23. PubMed ID: 28631222
    [No Abstract] [Full Text] [Related]

  • 6. Dysautonomia: A Forgotten Condition - Part 1.
    Rocha EA, Mehta N, Távora-Mehta MZP, Roncari CF, Cidrão AAL, Elias Neto J.
    Arq Bras Cardiol; 2021 Apr 04; 116(4):814-835. PubMed ID: 33886735
    [Abstract] [Full Text] [Related]

  • 7. L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure.
    Mathias CJ, Senard JM, Braune S, Watson L, Aragishi A, Keeling JE, Taylor MD.
    Clin Auton Res; 2001 Aug 04; 11(4):235-42. PubMed ID: 11710796
    [Abstract] [Full Text] [Related]

  • 8. Differential diagnosis of suspected neurogenic orthostatic hypotension in a patient with Parkinson disease.
    Lew M, Kremens D.
    Clin Auton Res; 2017 Jul 04; 27(Suppl 1):5-7. PubMed ID: 28674866
    [No Abstract] [Full Text] [Related]

  • 9. Droxidopa as an effective treatment for refractory neurogenic orthostatic hypotension and reflex bradycardia in amyloid light-chain amyloidosis: a case report.
    Ho AH, Kinter CW, Wight J, Neelam AR, Krakow D.
    J Med Case Rep; 2020 Jun 20; 14(1):73. PubMed ID: 32560740
    [Abstract] [Full Text] [Related]

  • 10. Droxidopa in neurogenic orthostatic hypotension.
    Kaufmann H, Norcliffe-Kaufmann L, Palma JA.
    Expert Rev Cardiovasc Ther; 2015 Jun 20; 13(8):875-91. PubMed ID: 26092297
    [Abstract] [Full Text] [Related]

  • 11. Diagnosing and treating neurogenic orthostatic hypotension in primary care.
    Kuritzky L, Espay AJ, Gelblum J, Payne R, Dietrich E.
    Postgrad Med; 2015 Jun 20; 127(7):702-15. PubMed ID: 26012731
    [Abstract] [Full Text] [Related]

  • 12. Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials.
    Chen JJ, Han Y, Tang J, Portillo I, Hauser RA, Dashtipour K.
    Ann Pharmacother; 2018 Dec 20; 52(12):1182-1194. PubMed ID: 29972032
    [Abstract] [Full Text] [Related]

  • 13. Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease.
    Kremens D, Lew M, Claassen D, Goodman BP.
    Clin Auton Res; 2017 Jul 20; 27(Suppl 1):29-31. PubMed ID: 28674867
    [No Abstract] [Full Text] [Related]

  • 14. Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension.
    Gupta F, Karabin B, Mehdirad A.
    Clin Auton Res; 2017 Jul 20; 27(Suppl 1):15-16. PubMed ID: 28699047
    [No Abstract] [Full Text] [Related]

  • 15. Reproducibility of orthostatic hypotension in symptomatic elderly.
    Ward C, Kenny RA.
    Am J Med; 1996 Apr 20; 100(4):418-22. PubMed ID: 8610728
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of droxidopa compared to midodrine in standing blood pressure and orthostatic tolerance in adults with neurogenic orthostatic hypotension: a systematic review protocol.
    Patrick K, Martin T.
    JBI Database System Rev Implement Rep; 2017 Sep 20; 15(9):2287-2294. PubMed ID: 28902695
    [Abstract] [Full Text] [Related]

  • 17. Supine plasma NE predicts the pressor response to droxidopa in neurogenic orthostatic hypotension.
    Palma JA, Norcliffe-Kaufmann L, Martinez J, Kaufmann H.
    Neurology; 2018 Oct 16; 91(16):e1539-e1544. PubMed ID: 30232253
    [Abstract] [Full Text] [Related]

  • 18. Droxidopa and Reduced Falls in a Trial of Parkinson Disease Patients With Neurogenic Orthostatic Hypotension.
    Hauser RA, Heritier S, Rowse GJ, Hewitt LA, Isaacson SH.
    Clin Neuropharmacol; 2016 Oct 16; 39(5):220-6. PubMed ID: 27332626
    [Abstract] [Full Text] [Related]

  • 19. Orthostatic Hypotension: A Practical Approach.
    Kim MJ, Farrell J.
    Am Fam Physician; 2022 Jan 01; 105(1):39-49. PubMed ID: 35029940
    [Abstract] [Full Text] [Related]

  • 20. Managing neurogenic orthostatic hypotension in a patient presenting with pure autonomic failure who later developed Parkinson disease.
    Gupta F, Kremens D, Vernino S, Karabin B.
    Clin Auton Res; 2017 Jul 01; 27(Suppl 1):9-11. PubMed ID: 28699048
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.